T2 Biosystems, Inc. Common Stock. $0.56 +0.1067 +23.54%. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers ...Korea Investment CORP lowered its position in shares of Boston Scientific Co. ( NYSE:BSX – Free Report) by 12.1% during the 1st quarter, according to the company in its most recent filing with ...Google Finance provides real-time market quotes, international exchanges, up-to-date financial news, and analytics to help you make more informed trading and investment decisions.The tech stock rally seen for most of the year has been taking a bit of a breather lately. However, considering the huge strides made by the big tech names in 2023, that hasn’t stopped market ...Aug 28, 2023 · Boston Scientific Corporation (NYSE:BSX)’s beta value is holding at 0.78, while the average true range (ATR) indicator is currently reading 0.83. Considering analysts have assigned the stock a price target range of $55.00-$68.00 as the low and high respectively, we find the trailing 12-month average consensus price target to be $60.50. BSX | July 27, 2023. MARLBOROUGH, Mass., July 27, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.599 billion during the second quarter of 2023, growing 11.0 percent on a reported basis, 12.0 percent on an operational 1 basis and 11.6 percent on an organic 2 basis, all compared to the prior year period.Boston Scientific Corporation (BSX) Stock Price, News, Quote & History - Yahoo Finance Boston Scientific Corporation (BSX) NYSE - Nasdaq Real Time Price. Currency in USD Follow 2W 10W 9M...Sep 12, 2023 · See the latest Boston Scientific Corp stock price (NYSE:BSX), related news, valuation, dividends and more to help you make your investing decisions. Boston Scientific Corporation (NYSE:NYSE:BSX) Q2 2023 Earnings Conference Call July 27, 2023 7:30 AM ETCompany ParticipantsLauren Tengler - VP, IRMike Mahoney - Chairman & CEODan...The latest price target for . Boston Scientific (NYSE: BSX) was reported by Mizuho on Monday, August 28, 2023.The analyst firm set a price target for 56.00 expecting BSX to rise to within 12 ... Boston Scientific Corporation (NYSE:BSX) shares, rose in value on Thursday, 09/07/23, with the stock price up by 0.06% to the previous day’s close as strong demand from buyers drove the stock to $53.89. Actively observing the price movement in the last trading, the stock closed the session at $53.86, falling within a range of $53.78 and $54.755.Boston Scientific (NYSE: BSX) and EndoChoice Holdings, Inc. (NYSE: GI) today announced the companies have entered into a definitive agreement under which Boston Scientific has agreed to acquire EndoChoice. Upon completion of. 2016-09-27: EX-99.1: BOSTON SCIENTIFIC TO ACQUIRE ENDOCHOICE Acquisition Will Expand Endoscopy Gastroenterology PortfolioApr 13, 2023 · Boston Scientific's estimated fair value is US$41.64 based on 2 Stage Free Cash Flow to Equity. Boston Scientific's US$51.11 share price signals that it might be 23% overvalued. The US$53.11 ... MARLBOROUGH, Mass., April 23, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration (FDA) approval for the LOTUS Edge ...Sep 2, 2023 · Boston Scientific Co. has a 1-year low of $37.74 and a 1-year high of $54.99. Boston Scientific ( NYSE:BSX - Get Free Report) last posted its quarterly earnings data on Thursday, July 27th. The medical equipment provider reported $0.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.04. Sep 5, 2023 · MARLBOROUGH, Mass., Sept. 5, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will host a meeting with the investor community to review its financial goals and long-term growth ... Aug 6, 2023 · Bellwether Advisors LLC increased its holdings in shares of Boston Scientific Co. (NYSE:BSX - Free Report) by 24.1% in the first quarter, according to its most recent filing with the SEC. The fund owned 48,337 shares of the medical equipment provider's stock after acquiring an additional 9,376 shar May 9, 2019 · MARLBOROUGH, Mass., May 9, 2019 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Vertiflex, Inc., a privately-held company which has developed and commercialized the Superion ® Indirect Decompression System, a minimally-invasive device used to improve physical function and reduce pain in patients with lumbar spinal ... Aug 30, 2023 · Korea Investment CORP lowered its position in shares of Boston Scientific Co. ( NYSE:BSX – Free Report) by 12.1% during the 1st quarter, according to the company in its most recent filing with ... BSX Q1'23 Performance Report. Through these activities, Boston Scientific has recorded Q1 revenues of $3.39bn- a 12.00% YoY increase-alongside a net income of $314.00mn- a 182.88% increase- and a ...Coastline Trust Co acquired a new stake in Boston Scientific Co. ( NYSE:BSX - Free Report) during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 5,250 shares of the medical equipment provider's stock, valued at approximately $263,000. Other large investors have also recently ...Sep 5, 2023 · Sectoral Asset Management Inc. lowered its position in Boston Scientific Co. (NYSE:BSX – Free Report) by 10.5% during the first quarter, according to its most recent Form 13F filing with the SEC ... Jun 15, 2022 · Boston Scientific (NYSE:BSX) announced today that it agreed with Synergy Innovation to purchase its majority stake in M.I. Tech.. Marlborough, Massachusetts-based Boston Scientific will acquire a ... Coastline Trust Co acquired a new stake in Boston Scientific Co. ( NYSE:BSX - Free Report) during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 5,250 shares of the medical equipment provider's stock, valued at approximately $263,000. Other large investors have also recently ...Jun 15, 2022 · Boston Scientific (NYSE:BSX) announced today that it agreed with Synergy Innovation to purchase its majority stake in M.I. Tech.. Marlborough, Massachusetts-based Boston Scientific will acquire a ... How much insider selling is happening at Boston Scientific? Insiders have sold a total of 1,620,273 Boston Scientific shares in the last 24 months for a total of $72,328,828.34 sold.MARLBOROUGH, Mass., Aug. 2, 2021 /PRNewswire/ -- Boston Scientific (NYSE: BSX) announced that the U.S. Centers for Medicare & Medicaid Services (CMS) granted a New Technology Add-on Payment (NTAP) for single-use duodenoscopes, applicable to the EXALT™ Model D Single-Use Duodenoscope, as part of its Fiscal Year 2022 Hospital Inpatient Prospective Payment System.cjn
Feb 1, 2023 · MARLBOROUGH, Mass., Feb. 1, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the fourth quarter of 2022, growing 3.7 percent on a reported basis, 8.7 percent on an operational 1 basis and 7.1 percent on an organic 2 basis, all compared to the prior Sep 11, 2023 · Ossiam lifted its position in shares of Boston Scientific Co. (NYSE:BSX - Free Report) by 262.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 61,441 shares of the medical equipment provider's stock after purchasing an On Jul 27, 2023, Boston Scientific ( NYSE: BSX) reported Q2 2023 earnings per share (EPS) of $0.18, up 5.88% year over year. Total Boston Scientific earnings for the quarter were $261.00 million. In the same quarter last year, Boston Scientific 's earnings per share (EPS) was $0.17. If you're new to stock investing, here's how to buy Boston ...MARLBOROUGH, Mass., Dec. 11, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) and Acotec Scientific Holdings Limited ("Acotec" and 6669.HK) announced today that Boston Scientific will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec, a Chinese medical technology company that offers solutions designed for a variety of interventional ...Jun 15, 2022 · MARLBOROUGH, Mass., June 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd, to purchase its majority stake (approximately 64 percent) of M.I.Tech Co., Ltd, ("M.I.Tech") a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures. The tech stock rally seen for most of the year has been taking a bit of a breather lately. However, considering the huge strides made by the big tech names in 2023, that hasn’t stopped market ...MARLBOROUGH, Mass., Aug. 15, 2022 / PRNewswire / -- Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Obsidio, Inc., a privately-held company that has developed the Gel Embolic Material (GEM ™) technology used for embolization of blood vessels in the peripheral vasculature. Embolization is a minimally invasive ...Feb 1, 2023 · MARLBOROUGH, Mass., Feb. 1, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the fourth quarter of 2022, growing 3.7 percent on a reported basis, 8.7 percent on an operational 1 basis and 7.1 percent on an organic 2 basis, all compared to the prior Oct 6, 2021 · 06 Oct, 2021, 07:00 ET. MARLBOROUGH, Mass., Oct. 6, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Baylis ... play wpt
How much insider selling is happening at Boston Scientific? Insiders have sold a total of 1,620,273 Boston Scientific shares in the last 24 months for a total of $72,328,828.34 sold.15 Wall Street analysts have issued 12-month price targets for Boston Scientific's stock. Their BSX share price forecasts range from $50.00 to $64.00. On average, they expect the company's share price to reach $58.50 in the next twelve months. This suggests a possible upside of 8.6% from the stock's current price.Jan 21, 2021 · MARLBOROUGH, Mass., Jan. 21, 2021 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Preventice Solutions, Inc., a privately-held company which offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors – including short and long-term Holter monitors – to cardiac ... The latest price target for . Boston Scientific (NYSE: BSX) was reported by Mizuho on Monday, August 28, 2023.The analyst firm set a price target for 56.00 expecting BSX to rise to within 12 ...MARLBOROUGH, Mass., Sept. 6, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration approval for the latest-generation ...Jul 27, 2023 · MARLBOROUGH, Mass., July 27, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.599 billion during the second quarter of 2023, growing 11.0 percent on a reported basis, 12.0 percent on an operational 1 basis and 11.6 percent on an organic 2 basis, all compared to the prior Home BSX • NYSE Boston Scientific Corporation Follow Share $53.87 After Hours: $53.92 (0.093%) +0.050 Closed: Sep 8, 5:03:29 PM GMT-4 · USD · NYSE · Disclaimer search Compare to Medtronic...BSX U.S.: NYSE Boston Scientific Corp. Watch list Open Last Updated: Sep 7, 2023 2:13 p.m. EDT Real time quote $ 54.19 0.33 0.61% Previous Close $53.86 Advanced Charting Volume: 4.29M 65 Day... Boston Scientific Corporation (BSX) NYSE - Nasdaq Real Time Price. Currency in USD. Follow. 2W 10W 9M. 53.87 -0.02 (-0.04%) At close: 04:00PM EDT. 53.51 -0.36 (-0.67%) After hours: 07:38PM... distribuidora corripio
According to the issued ratings of 16 analysts in the last year, the consensus rating for Boston Scientific stock is Buy based on the current 1 hold rating, 14 buy ratings and 1 strong buy rating for BSX. The average twelve-month price prediction for Boston Scientific is $58.50 with a high price target of $64.00 and a low price target of $50.00.Sep 8, 2023 · Boston Scientific Corporation (NYSE:BSX) shares, rose in value on Thursday, 09/07/23, with the stock price up by 0.06% to the previous day’s close as strong demand from buyers drove the stock to $53.89. Actively observing the price movement in the last trading, the stock closed the session at $53.86, falling within a range of $53.78 and $54.755. The trading price of Boston Scientific Corporation (NYSE:BSX) floating lower at last check on Tuesday, September 05, closing at $53.44, -0.34% lower than its previous close. Traders who pay close attention to intraday price movement should know that it has been fluctuating between $53.34 and $54.26. The company’s P/E ratio in the trailing 12 ...Aug 20, 2023 · Boston Scientific Co. (NYSE:BSX - Get Free Report) Director Charles J. Dockendorff sold 17,079 shares of Boston Scientific stock in a transaction that occurred on Friday, August 18th. The shares were sold at an average price of $50.74, for a total transaction of $866,588.46. Following the sale, the director now owns 3,946 shares of the company's stock, valued at $200,220.04. The transaction ... Boston Scientific Corporation (NYSE:BSX) shares, rose in value on Friday, 07/28/23, with the stock price down by -1.80% to the previous day’s close as strong demand from buyers drove the stock to $51.69. Actively observing the price movement in the last trading, the stock closed the session at $52.64, falling within a range of $51.16 and $53.11.Jun 5, 2023 · For example, the Boston Scientific Corporation ( NYSE:BSX) share price is 51% higher than it was five years ago, which is more than the market average. It's also good to see a healthy gain of 32% ... Aug 28, 2023 · Boston Scientific Corporation (NYSE:BSX)’s beta value is holding at 0.78, while the average true range (ATR) indicator is currently reading 0.83. Considering analysts have assigned the stock a price target range of $55.00-$68.00 as the low and high respectively, we find the trailing 12-month average consensus price target to be $60.50. Jun 15, 2022 · MARLBOROUGH, Mass., June 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd, to purchase its majority stake (approximately 64 percent) of M.I.Tech Co., Ltd, ("M.I.Tech") a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures. Boston Scientific's estimated fair value is US$41.64 based on 2 Stage Free Cash Flow to Equity. Boston Scientific's US$51.11 share price signals that it might be 23% overvalued. The US$53.11 ...Sep 7, 2023 · Boston Scientific Price Performance. Shares of NYSE:BSX opened at $53.86 on Thursday. The company has a quick ratio of 0.80, a current ratio of 1.29 and a debt-to-equity ratio of 0.46. Jul 27, 2023 · Boston Scientific Corporation (NYSE:NYSE:BSX) Q2 2023 Earnings Conference Call July 27, 2023 7:30 AM ETCompany ParticipantsLauren Tengler - VP, IRMike Mahoney - Chairman & CEODan... Bellwether Advisors LLC increased its holdings in shares of Boston Scientific Co. (NYSE:BSX - Free Report) by 24.1% in the first quarter, according to its most recent filing with the SEC. The fund owned 48,337 shares of the medical equipment provider's stock after acquiring an additional 9,376 sharlizard's thicket restaurant
Aug 25, 2023 · Boston Scientific Corporation (NYSE:BSX) trade information. Upright in the green during last session for gaining 0.16%, in the last five days BSX remained trading in the red while hitting it’s week-highest on Thursday, 08/24/23 when the stock touched $50.43 price level, adding 1.41% to its value on the day. Sep 5, 2023 · Sectoral Asset Management Inc. lowered its position in Boston Scientific Co. (NYSE:BSX – Free Report) by 10.5% during the first quarter, according to its most recent Form 13F filing with the SEC ... Feb 1, 2023 · Boston Scientific Corporation (NYSE:NYSE:BSX) Q4 2022 Results Conference Call February 1, 2023 8:00 AM ETCompany ParticipantsLauren Tengler - Vice President, Investor RelationsMike Mahoney... MARLBOROUGH, Mass., Aug. 19, 2019 / PRNewswire / -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of BTG plc. (LSE: BTG) pursuant to the previously announced scheme of arrangement. BTG develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases ...Feb 1, 2023 · MARLBOROUGH, Mass., Feb. 1, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the fourth quarter of 2022, growing 3.7 percent on a reported basis, 8.7 percent on an operational 1 basis and 7.1 percent on an organic 2 basis, all compared to the prior Sep 1, 2021 · Boston Scientific (NYSE:BSX) announced today that it completed the nearly $1.1 billion acquisition of the global surgical business of Lumenis.. Marlborough, Massachusetts–based Boston Scientific ... Research Boston Scientific's (NYSE:BSX) stock key valuation metrics while comparing it with its industry peers & market side by side. Dashboard Markets Discover Watchlist Portfolios Screener Boston Scientific CorporationNov 30, 2022 · The Boston-area medical device maker (NYSE: BSX) is set to buy Apollo Endosurgery Inc. (Nasdaq: APEN) at $10 a share, about a 60% premium over where it had been trading over the past week. According to the issued ratings of 16 analysts in the last year, the consensus rating for Boston Scientific stock is Buy based on the current 1 hold rating, 14 buy ratings and 1 strong buy rating for BSX. The average twelve-month price prediction for Boston Scientific is $58.50 with a high price target of $64.00 and a low price target of $50.00.Boston Scientific Stock Down 0.5 %. Shares of NYSE BSX opened at $52.92 on Friday. Boston Scientific Co. has a 12-month low of $37.74 and a 12-month high of $54.99. The company has a market ...Jul 29, 2023 · Boston Scientific Corporation (NYSE:BSX) shares, rose in value on Friday, 07/28/23, with the stock price down by -1.80% to the previous day’s close as strong demand from buyers drove the stock to $51.69. Actively observing the price movement in the last trading, the stock closed the session at $52.64, falling within a range of $51.16 and $53.11. Research Boston Scientific's (NYSE:BSX) stock key valuation metrics while comparing it with its industry peers & market side by side. Dashboard Markets Discover Watchlist Portfolios Screener Boston Scientific CorporationMARLBOROUGH, Mass., Feb. 1, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the fourth quarter of 2022, growing 3.7 percent on a reported basis, 8.7 percent on an operational 1 basis and 7.1 percent on an organic 2 basis, all compared to the prior year period.Hamilton, Bermuda — 10 February 2023 — The Bermuda Stock Exchange (BSX), a wholly owned subsidiary of Miami International Holdings, Inc., today reported its 2022 year-end results, with international debt listings and new listings of. Read more The BSX Rings the Bell for Financial Literacy and Announces New Investor Education Initiativereasons to vote for democrats bookIn May Boston Scientific Corporation (NYSE:BSX) cancelled its plan to buy a majority stake in the publicly listed Korean medical device maker M.I.Tech for $230 million amid regulatory concerns. 8.Mirova acquired a new stake in shares of Boston Scientific Co. (NYSE:BSX - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 8,700 shares of the medical equipment provider's stock, valued at approximately $Feb 1, 2023 · MARLBOROUGH, Mass., Feb. 1, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the fourth quarter of 2022, growing 3.7 percent on a reported basis, 8.7 percent on an operational 1 basis and 7.1 percent on an organic 2 basis, all compared to the prior MARLBOROUGH, Mass., Aug. 2, 2021 /PRNewswire/ -- Boston Scientific (NYSE: BSX) announced that the U.S. Centers for Medicare & Medicaid Services (CMS) granted a New Technology Add-on Payment (NTAP) for single-use duodenoscopes, applicable to the EXALT™ Model D Single-Use Duodenoscope, as part of its Fiscal Year 2022 Hospital Inpatient Prospective Payment System.Research Boston Scientific's (NYSE:BSX) stock key valuation metrics while comparing it with its industry peers & market side by side. Dashboard Markets Discover Watchlist Portfolios Screener Boston Scientific CorporationBleakley Financial Group LLC raised its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 3.0% in the first quarter, according to the company in its most recent Form 13F filing with ...MARLBOROUGH, Mass., Sept. 6, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration approval for the latest-generation ...Boston Scientific Corporation BSXNYSE BSXNYSE See on Supercharts Overview News Ideas Financials Technicals Forecast BSX chart Today 0.06% Week −1.23% 1 month 7.72% 6 months 14.51% Year to date 15.94% 1 year 33.69% 5 years 51.12% All time 1168.00% Key stats Market capitalization 78.863B USD Dividends yield (FY) — Price to earnings Ratio (TTM) 90.54Sep 12, 2023 · See the latest Boston Scientific Corp stock price (NYSE:BSX), related news, valuation, dividends and more to help you make your investing decisions. Bellwether Advisors LLC increased its holdings in shares of Boston Scientific Co. (NYSE:BSX - Free Report) by 24.1% in the first quarter, according to its most recent filing with the SEC. The fund owned 48,337 shares of the medical equipment provider's stock after acquiring an additional 9,376 sharCoastline Trust Co acquired a new stake in Boston Scientific Co. ( NYSE:BSX - Free Report) during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 5,250 shares of the medical equipment provider's stock, valued at approximately $263,000. Other large investors have also recently ...May 1, 2020 · Boston Scientific (NYSE: BSX) and EndoChoice Holdings, Inc. (NYSE: GI) today announced the companies have entered into a definitive agreement under which Boston Scientific has agreed to acquire EndoChoice. Upon completion of. 2016-09-27: EX-99.1: BOSTON SCIENTIFIC TO ACQUIRE ENDOCHOICE Acquisition Will Expand Endoscopy Gastroenterology Portfolio Mirova acquired a new stake in shares of Boston Scientific Co. (NYSE:BSX - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 8,700 shares of the medical equipment provider's stock, valued at approximately $the blues angry birds
May 9, 2019 · MARLBOROUGH, Mass., May 9, 2019 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Vertiflex, Inc., a privately-held company which has developed and commercialized the Superion ® Indirect Decompression System, a minimally-invasive device used to improve physical function and reduce pain in patients with lumbar spinal ... 15 Wall Street analysts have issued 12-month price targets for Boston Scientific's stock. Their BSX share price forecasts range from $50.00 to $64.00. On average, they expect the company's share price to reach $58.50 in the next twelve months. This suggests a possible upside of 8.6% from the stock's current price.Sep 7, 2023 · Boston Scientific Price Performance. Shares of NYSE:BSX opened at $53.86 on Thursday. The company has a quick ratio of 0.80, a current ratio of 1.29 and a debt-to-equity ratio of 0.46. Sep 12, 2023 · See the latest Boston Scientific Corp stock price (NYSE:BSX), related news, valuation, dividends and more to help you make your investing decisions. Jul 21, 2023 · Nisa Investment Advisors LLC boosted its position in shares of Boston Scientific Co. (NYSE:BSX - Free Report) by 3.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 334,482 shares of the medical equipmen The average Boston Scientific stock price prediction forecasts a potential upside of 9.83% from the current BSX share price of $53.87. What is BSX's forecast return on assets (ROA) for 2023-2026? (NYSE: BSX) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 0%. MARLBOROUGH, Mass., Feb. 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Baylis Medical Company Inc., a company that offers ...Boston Scientific Corporation (NYSE:NYSE:BSX) Q4 2022 Results Conference Call February 1, 2023 8:00 AM ETCompany ParticipantsLauren Tengler - Vice President, Investor RelationsMike Mahoney...Sep 8, 2023 · Boston Scientific Corporation (NYSE:BSX) shares, rose in value on Thursday, 09/07/23, with the stock price up by 0.06% to the previous day’s close as strong demand from buyers drove the stock to $53.89. Actively observing the price movement in the last trading, the stock closed the session at $53.86, falling within a range of $53.78 and $54.755. gapines
Feb 2, 2023 · February 2, 2023 at 3:58 PM · 21 min read. Boston Scientific Corporation (NYSE: BSX) Q4 2022 Earnings Call Transcript February 1, 2023. Operator: Good morning, and welcome to the Boston ... Boston Scientific Corp. BSX (U.S.: NYSE) Overview News Boston Scientific Corp. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) 90.55 ( 09/08/23) EPS (TTM)... Aug 30, 2023 · Korea Investment CORP lowered its position in shares of Boston Scientific Co. ( NYSE:BSX – Free Report) by 12.1% during the 1st quarter, according to the company in its most recent filing with ... How much insider selling is happening at Boston Scientific? Insiders have sold a total of 1,620,273 Boston Scientific shares in the last 24 months for a total of $72,328,828.34 sold.Nisa Investment Advisors LLC boosted its position in shares of Boston Scientific Co. (NYSE:BSX - Free Report) by 3.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 334,482 shares of the medical equipmen